CG Oncology
- Market cap
- 5.53B
- P/E (TTM)i
- -23.19
- P/Bi
- 5.37
- EPSi
- -2.08
- Div yieldi
- 0.00%
- 52W posi
- 59%
Anonymous reader poll. Unscientific, not investment advice.
CG Oncology shares were changing hands at 62.38, down 1.98% on the day. Its market capitalisation is about 5.53B, the #1929 most valuable US-listed company we track. Across 10 analysts the consensus rating is Buy, with an average price target of 92.56 (+48%). Against a 52-week band of 35.80-80.97, the shares are currently 59% of the way up.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 1 day.
- Recent price momentum is +27.2% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 12.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 63.64
- Open
- 62.68
- Day range
- 61.90 - 63.64
- Avg price
- 62.68
- Volume
- 621.82K
- Turnover
- 38.98M
- Turnover ratei
- 0.91%
- Volume ratioi
- 0.57
- Amplitudei
- 2.73%
- 52-week rangei
- 35.80 - 80.97
Valuation
- P/Ei
- -29.99
- P/E (TTM)i
- -23.19
- P/Bi
- 5.37
- EPSi
- -2.08
- Book value / shi
- 11.61
- Net profit
- -184.37M
- Net assets
- 1.03B
Share structure
- Market cap
- 5.53B
- Float capi
- 4.26B
- Shares out
- 88.64M
- Float sharesi
- 68.28M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2024-01-25
23.0% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-18.76M net over the window
Short interest
- Shares short
- 11.25M
- % of floati
- 12.70%
- Days to coveri
- 17.01
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of CG Oncology (CGON)?
CG Oncology last traded at 62.38. The quote on this page refreshes every few seconds while US markets are open.
What is CG Oncology's market cap?
About 5.53B.
What is the P/E ratio of CG Oncology?
The trailing twelve-month P/E is -23.19. The Valuation tab shows it against the stock's own five-year range.
Does CG Oncology pay a dividend?
CG Oncology does not currently pay a regular dividend.
Is CG Oncology a buy according to analysts?
The consensus of 10 analysts is a Buy rating, with an average 12-month price target of 92.56, which implies 48.4% upside from the current price. This is not investment advice.
What is CG Oncology's StockVane Quant Rating?
The StockVane Momentum strategy currently rates CG Oncology a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 04:49:36 · For reference only, not investment advice and not tailored to your situation.